Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 8, Pages 2252
Publisher
MDPI AG
Online
2020-08-12
DOI
10.3390/cancers12082252
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Glucose Transporters for Breast Cancer Therapy: The Effect of Natural and Synthetic Compounds
- (2020) Ana M. Barbosa et al. Cancers
- Metabolic Symbiosis in Chemoresistance: Refocusing the Role of Aerobic Glycolysis
- (2020) Lisi Ma et al. Frontiers in Oncology
- Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression
- (2020) Elizabeth Varghese et al. Biomolecules
- Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK
- (2020) Nurbubu T. Moldogazieva et al. Cancers
- Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib+
- (2020) Nicla Lorito et al. Cells
- Metabolic Reprogramming in Triple-Negative Breast Cancer
- (2020) Xiangyu Sun et al. Frontiers in Oncology
- Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
- (2019) Tengjiao Fan et al. Cancers
- Downregulation of hexokinase 2 improves radiosensitivity of breast cancer
- (2019) Dan Zhang et al. Translational Cancer Research
- Targeting the ROS/PI3K/AKT/HIF‐1α/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2‐Deoxy‐d‐glucose
- (2019) Tao Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer
- (2019) Hiroshi Sawayama et al. CANCER SCIENCE
- The roles of glucose metabolic reprogramming in chemo- and radio-resistance
- (2019) Jinguan Lin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells
- (2019) Fei Chen et al. NATURE CELL BIOLOGY
- Metformin prevention of doxorubicin resistance in MCF-7 and MDA-MB-231 involves oxidative stress generation and modulation of cell adaptation genes
- (2019) Poliana Camila Marinello et al. Scientific Reports
- Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides
- (2019) Elodie Villa et al. Cancers
- Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment
- (2019) Deepshikha Mishra et al. Cancers
- Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer
- (2019) Chandan Kanta Das et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy
- (2019) Angara Zambrano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chidamide suppresses the glycolysis of triple negative breast cancer cells partially by targeting the miR‑33a‑5p‑LDHA axis
- (2019) Xiangdong Bai et al. Molecular Medicine Reports
- SGLT1 is required for the survival of triple‐negative breast cancer cells via potentiation of EGFR activity
- (2019) Huiquan Liu et al. Molecular Oncology
- Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades
- (2019) Michelle K. Y. Siu et al. Cancers
- Wnt Signaling in Cancer Metabolism and Immunity
- (2019) Sara El-Sahli et al. Cancers
- Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical Trials
- (2019) Rola El Sayed et al. Frontiers in Oncology
- Ursolic Acid Reverses the Chemoresistance of Breast Cancer Cells to Paclitaxel by Targeting MiRNA-149-5p/MyD88
- (2019) Fenfen Xiang et al. Frontiers in Oncology
- Mechanisms and Implications of Metabolic Heterogeneity in Cancer
- (2019) Jiyeon Kim et al. Cell Metabolism
- Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors
- (2019) Patrizia Cancemi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Elevated Hexokinase II Expression Confers Acquired Resistance to 4-Hydroxytamoxifen in Breast Cancer Cells
- (2019) Xiaochuan Liu et al. MOLECULAR & CELLULAR PROTEOMICS
- Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis
- (2019) Benjamin L. Woolbright et al. MOLECULAR CANCER THERAPEUTICS
- Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy
- (2019) Monika Marcinkowska et al. PHARMACEUTICAL RESEARCH
- Hexokinase 2 dimerization and interaction with voltage‐dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer
- (2019) Kun Fan et al. Cancer Medicine
- Pathways to Endocrine Therapy Resistance in Breast Cancer
- (2019) Md. Moquitul Haque et al. Frontiers in Endocrinology
- Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker
- (2019) Giacomo Pelizzari et al. Cancers
- Flavonoid GL-V9 induces apoptosis and inhibits glycolysis of breast cancer via disrupting GSK-3β-modulated mitochondrial binding of HKII
- (2019) Yongjian Guo et al. FREE RADICAL BIOLOGY AND MEDICINE
- Paclitaxel in breast cancer – drug resistance and strategies to counteract it
- (2019) Alicja Zajdel et al. Postepy Higieny I Medycyny Doswiadczalnej
- The role of pyruvate kinase M2 in anticancer therapeutic treatments (Review)
- (2019) Qiongli Su et al. Oncology Letters
- Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells
- (2019) Daniele Cretella et al. Scientific Reports
- Quantitative Spatial Analysis of Metabolic Heterogeneity Across in vivo and in vitro Tumor Models
- (2019) Tiffany M. Heaster et al. Frontiers in Oncology
- Reprogramming of fatty acid metabolism in cancer
- (2019) Nikos Koundouros et al. BRITISH JOURNAL OF CANCER
- Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
- (2019) Samson Mathews Samuel et al. Biomolecules
- Effect of pyruvate kinase M2-regulating aerobic glycolysis on chemotherapy resistance of estrogen receptor-positive breast cancer
- (2018) Yuejun Qian et al. ANTI-CANCER DRUGS
- Quercetin inhibits glucose transport by binding to an exofacial site on GLUT1
- (2018) Kathryn E. Hamilton et al. BIOCHIMIE
- Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins
- (2018) Carrie J. Lovitt et al. BMC CANCER
- FGFR4 Links Glucose Metabolism and Chemotherapy Resistance in Breast Cancer
- (2018) Min Xu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Effects of a Series of Acidic Drugs on L-Lactic Acid Transport by the Monocarboxylate Transporters MCT1 and MCT4
- (2018) Yat H. Leung et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Inhibition of Pyruvate Dehydrogenase Kinase as a Therapeutic Strategy against Cancer
- (2018) Swatishree Sradhanjali et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Evolution of GAPDH as a druggable target of tumor glycolysis?
- (2018) Shanmugasundaram Ganapathy-Kanniappan EXPERT OPINION ON THERAPEUTIC TARGETS
- Silybin counteracts doxorubicin resistance by inhibiting GLUT1 expression
- (2018) Daniela Catanzaro et al. FITOTERAPIA
- PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis
- (2018) Fang Peng et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Diagnostic value of α-enolase expression and serum α-enolase autoantibody levels in lung cancer
- (2018) Lihong Zhang et al. Jornal Brasileiro de Pneumologia
- Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction
- (2018) Lijun Jia et al. LIFE SCIENCES
- Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling
- (2018) Ming-Chuan Hsu et al. Molecular Cancer
- PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer
- (2018) Tingting Yang et al. ONCOGENE
- Shikonin, vitamin K3 and vitamin K5 inhibit multiple glycolytic enzymes in MCF-7 cells
- (2018) Jing Chen et al. Oncology Letters
- Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects
- (2018) Cyril Corbet et al. Nature Communications
- Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States
- (2018) Dongya Jia et al. Cells
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Challenges and perspectives in the treatment of diabetes associated breast cancer
- (2018) Samson Mathews Samuel et al. CANCER TREATMENT REVIEWS
- Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
- (2018) Susmita Mondal et al. INTERNATIONAL JOURNAL OF CANCER
- Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer
- (2018) Lorenzo Castagnoli et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
- (2018) Elizabeth Varghese et al. Cancers
- LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma
- (2018) Xiao-ming Hou et al. BIOSCIENCE REPORTS
- Combined use of arginase and dichloroacetate exhibits anti-proliferative effects in triple negative breast cancer cells
- (2018) Angela Verma et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- The Influence of Metabolism on Drug Response in Cancer
- (2018) Esther A. Zaal et al. Frontiers in Oncology
- Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin
- (2018) Li Zong et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Drug Resistance Driven by Cancer Stem Cells and Their Niche
- (2017) Marta Prieto-Vila et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer
- (2017) Yiming Yang et al. MEDICINE
- Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
- (2017) Angela DeMichele et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia
- (2017) F Peng et al. ONCOGENE
- Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis
- (2017) L Jin et al. ONCOGENE
- Insulin-induced enhancement of MCF-7 breast cancer cell response to 5-fluorouracil and cyclophosphamide
- (2017) Siddarth Agrawal et al. TUMOR BIOLOGY
- Targeting Metabolic Remodeling in Triple Negative Breast Cancer in a Murine Model
- (2017) Verónica García-Castillo et al. Journal of Cancer
- Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro
- (2017) Maruša Bizjak et al. Scientific Reports
- High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer
- (2016) Xiaojia Huang et al. BREAST
- Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer
- (2016) Julie O’Neal et al. BREAST CANCER RESEARCH AND TREATMENT
- EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape
- (2016) S.-O. Lim et al. CANCER RESEARCH
- Combination of metformin and sorafenib suppresses proliferation and induces autophagy of hepatocellular carcinoma via targeting the mTOR pathway
- (2016) Sunbin Ling et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The importance of serine metabolism in cancer
- (2016) Katherine R. Mattaini et al. JOURNAL OF CELL BIOLOGY
- Cancer heterogeneity is not compatible with one unique cancer cell metabolic map
- (2016) A Strickaert et al. ONCOGENE
- Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters
- (2016) Vlasta Němcová-Fürstová et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- Anticancer agents interacting with membrane glucose transporters
- (2016) C. Granchi et al. MedChemComm
- Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies
- (2016) Jiayuan Wu et al. OncoTargets and Therapy
- Dichloroacetate potentiates tamoxifen-induced cell death in breast cancer cells via downregulation of the epidermal growth factor receptor
- (2016) Sang Hyeok Woo et al. Oncotarget
- MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4
- (2016) Candice Sun Hong et al. Cell Reports
- A Novel Agent Enhances the Chemotherapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells
- (2016) Liang Wang et al. Frontiers in Pharmacology
- Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines
- (2015) Yasmin M. Attia et al. BMC CANCER
- HER2 and β-catenin protein location: importance in the prognosis of breast cancer patients and their correlation when breast cancer cells suffer stressful situations
- (2015) F. Darío Cuello-Carrión et al. CLINICAL & EXPERIMENTAL METASTASIS
- Palbociclib for the Treatment of Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
- (2015) A. Morikawa et al. CLINICAL CANCER RESEARCH
- Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?
- (2015) Wen Zhang et al. International Journal of Biological Sciences
- The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents
- (2015) Elise Saunier et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular aspects of breast cancer resistance to drugs (Review)
- (2015) GLORIA M. CALAF et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Side-effects of cancer drugs are under-reported in trials
- (2015) Susan Mayor LANCET ONCOLOGY
- Dichloroacetate restores drug sensitivity in paclitaxel-resistant cells by inducing citric acid accumulation
- (2015) Xiang Zhou et al. Molecular Cancer
- FV-429 induces apoptosis and inhibits glycolysis by inhibiting Akt-mediated phosphorylation of hexokinase II in MDA-MB-231 cells
- (2015) Yuxin Zhou et al. MOLECULAR CARCINOGENESIS
- Combination of temozolomide and Taxol exerts a synergistic inhibitory effect on Taxol-resistant glioma cells via inhibition of glucose metabolism
- (2015) DING-GUO GUAN et al. Molecular Medicine Reports
- The Chemopreventive Effect of the Dietary Compound Kaempferol on the MCF-7 Human Breast Cancer Cell Line Is Dependent on Inhibition of Glucose Cellular Uptake
- (2015) Cláudia Azevedo et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Pyruvate kinase: Function, regulation and role in cancer
- (2015) William J. Israelsen et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- The role of taxanes in triple-negative breast cancer: literature review
- (2015) Giorgio Mustacchi et al. Drug Design Development and Therapy
- Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death
- (2015) Daniela Catanzaro et al. Oncotarget
- Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest
- (2015) Michela Capello et al. Oncotarget
- Natural Compounds Regulate Glycolysis in Hypoxic Tumor Microenvironment
- (2015) Jian-Li Gao et al. Biomed Research International
- High Expression of Pyruvate Kinase M2 is Associated with Chemosensitivity to Epirubicin and 5-Fluorouracil in Breast Cancer
- (2015) Yang Lin et al. Journal of Cancer
- Altered regulation of PDK4 expression promotes antiestrogen resistance in human breast cancer cells
- (2015) William Walter et al. SpringerPlus
- Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells
- (2015) Yu Mi Woo et al. PLoS One
- Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
- (2015) Sílvia Cufí et al. Oncotarget
- Establishment of Paclitaxel-resistant Breast Cancer Cell Line and Nude Mice Models, and Underlying Multidrug Resistance Mechanisms in Vitro and in Vivo
- (2014) Si-Ying Chen et al. Asian Pacific Journal of Cancer Prevention
- Targeting of two aspects of metabolism in breast cancer treatment
- (2014) Bevan P Gang et al. CANCER BIOLOGY & THERAPY
- Overexpression of MicroRNA-122 Re-sensitizes 5-FU-Resistant Colon Cancer Cells to 5-FU Through the Inhibition of PKM2 In Vitro and In Vivo
- (2014) Jinxia He et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells
- (2014) Qiang Yang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer
- (2014) Edward B. Garon et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Glycolysis inhibition and its effect in doxorubicin resistance in neuroblastoma
- (2014) Jonathan F. Bean et al. JOURNAL OF PEDIATRIC SURGERY
- Synergistic Anti-Cancer Effect of Phenformin and Oxamate
- (2014) W. Keith Miskimins et al. PLoS One
- Sensitizing the Therapeutic Efficacy of Taxol with Shikonin in Human Breast Cancer Cells
- (2014) Wenjuan Li et al. PLoS One
- Serine and glycine metabolism in cancer
- (2014) Ivano Amelio et al. TRENDS IN BIOCHEMICAL SCIENCES
- Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment
- (2014) D Ciavardelli et al. Cell Death & Disease
- Hexokinase II in breast carcinoma: A potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67
- (2013) Akiko Sato-Tadano et al. CANCER SCIENCE
- Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer
- (2013) Cecilia Marini et al. CELL CYCLE
- Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2013) J. B. Dennison et al. CLINICAL CANCER RESEARCH
- Relationships between LDH-A, Lactate, and Metastases in 4T1 Breast Tumors
- (2013) A. Rizwan et al. CLINICAL CANCER RESEARCH
- Differential sensitivities to lactate transport inhibitors of breast cancer cell lines
- (2013) Filipa Morais-Santos et al. ENDOCRINE-RELATED CANCER
- Establishment of a Paclitaxel Resistant Human Breast Cancer Cell Strain (MCF-7/Taxol) and Intracellular Paclitaxel Binding Protein Analysis
- (2013) K-Q Zuo et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Metformin reverses multidrug resistance and epithelial–mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells
- (2013) Chen Qu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Cetuximab Reverses the Warburg Effect by Inhibiting HIF-1-Regulated LDH-A
- (2013) H. Lu et al. MOLECULAR CANCER THERAPEUTICS
- Glucose conjugation for the specific targeting and treatment of cancer
- (2013) Emilia C. Calvaresi et al. Chemical Science
- Succinate dehydrogenase expression in breast cancer
- (2013) Sewha Kim et al. SpringerPlus
- Tamoxifen Resistance in Breast Cancer
- (2012) Min-Sun Chang Biomolecules & Therapeutics
- A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
- (2012) Luis E. Raez et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer
- (2012) A.M. Gonzalez-Angulo et al. CANCER TREATMENT REVIEWS
- Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells
- (2012) Yong Yang et al. CELL BIOCHEMISTRY AND FUNCTION
- Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways
- (2012) F. Farabegoli et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The Multiple Facets of Dermcidin in Cell Survival and Host Defense
- (2012) Birgit Schittek Journal of Innate Immunity
- A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo
- (2012) Y. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers
- (2012) Anna Krzeslak et al. PATHOLOGY & ONCOLOGY RESEARCH
- Overexpression of Pyruvate Dehydrogenase Kinase 3 Increases Drug Resistance and Early Recurrence in Colon Cancer
- (2011) Chun-Wun Lu et al. AMERICAN JOURNAL OF PATHOLOGY
- Hexose Transporter GLUT1 Harbors Several Distinct Regulatory Binding Sites for Flavones and Tyrphostins
- (2011) Alejandra Pérez et al. BIOCHEMISTRY
- Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism
- (2011) Y. Zhao et al. CANCER RESEARCH
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
- (2011) Ramon C Sun et al. Molecular Cancer
- Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells
- (2011) Ayako Nakano et al. PLoS One
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer
- (2010) Tomomi Egawa-Takata et al. CANCER SCIENCE
- Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing via H2O2-mediated oxidative stress
- (2010) Tanja Hadzic et al. FREE RADICAL BIOLOGY AND MEDICINE
- Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
- (2010) Ming Zhou et al. Molecular Cancer
- Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells
- (2010) Patricia Zancan et al. MOLECULAR GENETICS AND METABOLISM
- Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection
- (2010) Sherene Loi et al. OncoTargets and Therapy
- Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical-translational research experience at the Catalan Institute of Oncology
- (2009) B. Martin-Castillo et al. ANNALS OF ONCOLOGY
- Increased expression of enolase α in human breast cancer confers tamoxifen resistance in human breast cancer cells
- (2009) Shih-Hsin Tu et al. BREAST CANCER RESEARCH AND TREATMENT
- Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo
- (2009) Ramon C. Sun et al. BREAST CANCER RESEARCH AND TREATMENT
- Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
- (2009) Teemu T. Junttila et al. CANCER CELL
- Evaluation of the Role of Hexokinase Type II in Cellular Proliferation and Apoptosis Using Human Hepatocellular Carcinoma Cell Lines
- (2009) K. J. Ahn et al. JOURNAL OF NUCLEAR MEDICINE
- Induction of Akt Activity by Chemotherapy Confers Acquired Resistance
- (2009) Wei-Chien Huang et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
- (2009) Shanta Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization
- (2008) Elizabeth Iorns et al. BIOCHEMICAL JOURNAL
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
- (2008) Heather R. Christofk et al. NATURE
- Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer
- (2008) A Rodriguez-Gonzalez et al. ONCOGENE
- Arsenic trioxide in environmentally and clinically relevant concentrations interacts with calcium homeostasis and induces cell type specific cell death in tumor and non-tumor cells
- (2008) Ana-Maria Florea et al. TOXICOLOGY LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More